Keywords: Sanofi, Genzyme, Financial results, Second-quarter 2012

Sanofi 2nd-qtr hit by Plavix competition but group sales still up 6%

Article | 27 July 2012

French pharma major Sanofi (Euronext: SAN) reported second-quarter 2012 financial results with net sales growing 6.2% (+0.4% at constant currencies) to 8.87 billion euros ($10.79 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sanofi

Genzyme

Go to company listing